20 Aug 2024

Hone your skills, confidence in referring patients to mental health services

If you have not already participated in SWSPHN’s Initial Assessment and Referral for mental healthcare workshop, register for a face-to-face workshop in September.

20 Aug 2024

Reminder: be part of our first General Practice Census\

Thanks to those practices who’ve returned their General Practice Census. For those who haven’t, please return your completed General Practice Census and help create a ‘snapshot’ of the current workforce climate in our region

20 Aug 2024

Easy and quick to access Urgent Care medical services attract 10,000 patients

SWSPHN’s commitment to providing accessible and timely healthcare has reached an impressive milestone with more than 10,000 patients treated at Urgent Care sites across our region.

20 Aug 2024

Annual cycle of care helps patients manage their diabetes

GPs can support their patients by using the diabetes cycle of care.

19 Aug 2024

Australia’s child vaccination rates are world-leading. Our adult rates are not.

Australia’s woeful adult vaccination rates could be significantly bolstered if they were promoted better and made cheaper and easier for people to obtain.

19 Aug 2024

What does the mpox emergency mean for GPs?

Experts are urging Australian GPs to be on the lookout for symptoms among their patients, after the outbreak was declared a global emergency.

19 Aug 2024

Incentivised training placements reduce registrar shortfall

Workforce shortage woes are starting to ease as RACGP incentive placements put 177 registrars in areas of urgent need, but there is still work to be done by government

19 Aug 2024

224 new GP fellows for NSW

The fellows will now embark on the next stage of their career, with the RACGP President saying they are needed ‘more than ever’.

19 Aug 2024

PBAC Update August 2024

PBAC Update August 2024

19 Aug 2024

New PBS listing for migalastat (Galafold®) for the treatment of Fabry disease

On 1 September 2024, migalastat (Galafold®) will become available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of Fabry disease under certain circumstances.